Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15540788rdf:typepubmed:Citationlld:pubmed
pubmed-article:15540788lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:15540788lifeskim:mentionsumls-concept:C0234421lld:lifeskim
pubmed-article:15540788lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:15540788lifeskim:mentionsumls-concept:C0042059lld:lifeskim
pubmed-article:15540788lifeskim:mentionsumls-concept:C0439799lld:lifeskim
pubmed-article:15540788lifeskim:mentionsumls-concept:C0530684lld:lifeskim
pubmed-article:15540788lifeskim:mentionsumls-concept:C1879743lld:lifeskim
pubmed-article:15540788pubmed:issue5 Pt 1lld:pubmed
pubmed-article:15540788pubmed:dateCreated2004-11-15lld:pubmed
pubmed-article:15540788pubmed:abstractTextRetigabine is a novel anticonvulsant drug that not only augments gamma-aminobutyric acid mechanisms, but also opens voltage gated K+ channels (KCNQ). In this study we investigated the effects of retigabine on detrusor activity in rats.lld:pubmed
pubmed-article:15540788pubmed:languageenglld:pubmed
pubmed-article:15540788pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15540788pubmed:citationSubsetAIMlld:pubmed
pubmed-article:15540788pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15540788pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15540788pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15540788pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15540788pubmed:statusMEDLINElld:pubmed
pubmed-article:15540788pubmed:monthNovlld:pubmed
pubmed-article:15540788pubmed:issn0022-5347lld:pubmed
pubmed-article:15540788pubmed:authorpubmed-author:AnderssonKarl...lld:pubmed
pubmed-article:15540788pubmed:authorpubmed-author:ChristophThom...lld:pubmed
pubmed-article:15540788pubmed:authorpubmed-author:StrengTomiTlld:pubmed
pubmed-article:15540788pubmed:issnTypePrintlld:pubmed
pubmed-article:15540788pubmed:volume172lld:pubmed
pubmed-article:15540788pubmed:ownerNLMlld:pubmed
pubmed-article:15540788pubmed:authorsCompleteYlld:pubmed
pubmed-article:15540788pubmed:pagination2054-8lld:pubmed
pubmed-article:15540788pubmed:meshHeadingpubmed-meshheading:15540788...lld:pubmed
pubmed-article:15540788pubmed:meshHeadingpubmed-meshheading:15540788...lld:pubmed
pubmed-article:15540788pubmed:meshHeadingpubmed-meshheading:15540788...lld:pubmed
pubmed-article:15540788pubmed:meshHeadingpubmed-meshheading:15540788...lld:pubmed
pubmed-article:15540788pubmed:meshHeadingpubmed-meshheading:15540788...lld:pubmed
pubmed-article:15540788pubmed:meshHeadingpubmed-meshheading:15540788...lld:pubmed
pubmed-article:15540788pubmed:meshHeadingpubmed-meshheading:15540788...lld:pubmed
pubmed-article:15540788pubmed:meshHeadingpubmed-meshheading:15540788...lld:pubmed
pubmed-article:15540788pubmed:meshHeadingpubmed-meshheading:15540788...lld:pubmed
pubmed-article:15540788pubmed:meshHeadingpubmed-meshheading:15540788...lld:pubmed
pubmed-article:15540788pubmed:year2004lld:pubmed
pubmed-article:15540788pubmed:articleTitleUrodynamic effects of the K+ channel (KCNQ) opener retigabine in freely moving, conscious rats.lld:pubmed
pubmed-article:15540788pubmed:affiliationDepartment of Clinical and Experimental Pharmacology, Lund University Hospital, Lund, Sweden.lld:pubmed
pubmed-article:15540788pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15540788lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15540788lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15540788lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15540788lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15540788lld:pubmed